IntroductionDysbiosis in gut microbiota is associated with inflammatory bowel diseases (IBD), such as Crohn’s disease. Prohibitin 1 (PHB1) is a mitochondrial protein important in optimal mitochondrial respiration and is decreased in biopsies from IBD patients. Intestinal epithelial mitochondrial dysfunction is emerging as an underlying contributor to inflammation in IBD. Previous studies from our laboratory have demonstrated that mice with Phb1‐deficiency in the intestinal epithelium (Phb1iΔIEC) manifest mitochondrial dysfunction, Paneth cell defects, and spontaneous inflammation in the ileum with a penetrance of 87% at 12 weeks after inducing Phb1 deletion. This inflammation is associated with a reduction in the abundance of short chain acid (SCFA)‐producing bacteria, such as Blautia, Roseburia, Ruminococcus, and Coprococccus. However, little is known whether gut dysbiosis is a driver or consequence of ileitis during intestinal epithelial mitochondrial dysfunction. In the present study, we hypothesized that the gut microbiota is necessary to induce intestinal inflammation during epithelial cell mitochondrial dysfunction.MethodsPhb1iΔIEC mice and control Phb1fl/fllittermates were co‐housed and treated with broad spectrum antibiotics (ABX) (1 g/L ampicillin sodium salt, 1 g/L neomycin sulfate, 1 g/L metronidazole, and 500 mg/L vancomycin) in autoclaved drinking water for 4 weeks beginning 8 weeks after the induction of Phb1 deletion. Ileal stools were collected for 16S rRNA sequencing and quantification of SCFAs by liquid chromatography‐mass spectrometry. Ileum was collected for histological (inflammation) scoring after H&E staining and for immunofluorescent staining of lysozyme and Muc2 to quantitate Paneth cell defects (lysozyme allocation patterns, increase of lysozyme+/Muc2+ staining, and crypts devoid of lysozyme+ cells). Spleen weight was also measured at the time of sacrifice.ResultsIleal stool from Phb1iΔIEC mice exhibited a significant reduction in the SCFA butyrate compared to Phb1fl/fl littermates. 16S rRNA sequencing showed that ABX treatment abolished the ileal bacterial population in both Phb1fl/fland Phb1iΔIEC mice. ABX treatment ameliorated enlarged spleen weights, histological inflammation, and Paneth cell defects characteristic of Phb1iΔIEC mice to measurements noted in Phb1fl/fl mice.ConclusionsThese results suggest that mitochondrial dysfunction in IECs on its own is not sufficient to cause inflammation, but triggers disease when coupled with gut microbiota interaction. This is especially relevant to IBD given the prevalence of epithelial mitochondrial dysfunction in these patients.